MST CONTINUS suspension 20 mg Irlanda - inglês - HPRA (Health Products Regulatory Authority)

mst continus suspension 20 mg

mundipharma pharmaceuticals limited - morphine sulfate - prolonged-release granules for oral suspension - 20 milligram(s) - natural opium alkaloids; morphine

OXYCONTIN 60 Milligram Tablet Prolonged Release Irlanda - inglês - HPRA (Health Products Regulatory Authority)

oxycontin 60 milligram tablet prolonged release

mundipharma pharmaceuticals limited - oxycodone hydrochloride - tablet prolonged release - 60 milligram - natural opium alkaloids

OXYCONTIN 120 Milligram Tablet Prolonged Release Irlanda - inglês - HPRA (Health Products Regulatory Authority)

oxycontin 120 milligram tablet prolonged release

mundipharma pharmaceuticals limited - oxycodone hydrochloride - tablet prolonged release - 120 milligram - natural opium alkaloids

OXYCONTIN 15 Milligram Tablet Prolonged Release Irlanda - inglês - HPRA (Health Products Regulatory Authority)

oxycontin 15 milligram tablet prolonged release

mundipharma pharmaceuticals limited - oxycodone hydrochloride - tablet prolonged release - 15 milligram - natural opium alkaloids

OXYCONTIN 160 Milligram Tablet Prolonged Release Irlanda - inglês - HPRA (Health Products Regulatory Authority)

oxycontin 160 milligram tablet prolonged release

mundipharma pharmaceuticals limited - oxycodone hydrochloride - tablet prolonged release - 160 milligram - natural opium alkaloids

OXYCONTIN 30 Milligram Tablet Prolonged Release Irlanda - inglês - HPRA (Health Products Regulatory Authority)

oxycontin 30 milligram tablet prolonged release

mundipharma pharmaceuticals limited - oxycodone hydrochloride - tablet prolonged release - 30 milligram - natural opium alkaloids

ELIGARD leuprorelin acetate 30mg modified release injection syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

eligard leuprorelin acetate 30mg modified release injection syringe

mundipharma pty ltd - leuprorelin acetate, quantity: 30 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - prostate cancer,eligard 7.5mg 1 month, eligard 22.5mg 3 month, eligard 30mg 4 month and eligard 45mg 6 month are indicated for the:,? palliative treatment of advanced prostate cancer.,? treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy.

ELIGARD leuprorelin acetate 22.5mg modified release injection syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

eligard leuprorelin acetate 22.5mg modified release injection syringe

mundipharma pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - prostate cancer,eligard 7.5mg 1 month, eligard 22.5mg 3 month, eligard 30mg 4 month and eligard 45mg 6 month are indicated for the:,? palliative treatment of advanced prostate cancer.,? treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy.

ELIGARD leuprorelin acetate 7.5mg modified release injection syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

eligard leuprorelin acetate 7.5mg modified release injection syringe

mundipharma pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - eligard 7.5mg 1 month, eligard 22.5mg 3 month, eligard 30mg 4 month and eligard 45mg 6 month are indicated for the:,? palliative treatment of advanced prostate cancer.,? treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy.1

Mundipharma Burnaid Burn Gel Cingapura - inglês - HSA (Health Sciences Authority)

mundipharma burnaid burn gel

pan-malayan pharmaceuticals pte ltd - physical medicine - to cool and soothe minor burns, scalds and sunburns.